Hennion & Walsh Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$1.09M	Sell
2024 Q4	$2.05M	Sell
2024 Q3	$2.09M	Sell
2024 Q2	$1.85M	Buy
2024 Q1	$1.78M	Buy
2023 Q4	$1.32M	Buy
2023 Q3	$1.03M	Buy
2023 Q2	$329K	Buy